UBS’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

UBS’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-400	Closed	-$2K	–	10995
2014 Q2	$2K	Sell	400 -5,300	-93%	-$22.5K	﹤0.01%	10113
2014 Q1	$30K	Buy	5,700 +3,672	+181%	+$20.6K	﹤0.01%	7551
2013 Q4	$11K	Buy	+2,028	New	+$8.74K	﹤0.01%	8918
2013 Q3	–	Sell	-2,941	Closed	-$13K	–	10886
2013 Q2	$13K	Buy	+2,941	New	+$14.8K	﹤0.01%	8382

Other funds holding SGYP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

UBS's SGYP Position: Q3 2014 in Review

UBS increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 6.2% in Q3 2014, buying an estimated $20.3K and bringing the position to 95,500 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #4895.

UBS first reported a position in SGYP in Q3 2013 and has held it in 5 quarters since. The position peaked at $716K in Q1 2014. 78 funds tracked by Wall St. Rank hold SGYP as of Q3 2014.

UBS held 95,500 shares of Synergy Pharmaceuticals, Inc Common Stock worth $266K as of Q3 2014.
UBS bought 5,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2014, an estimated $20.3K.
Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4895 holding.
UBS first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and has held it in 5 quarters since.
UBS's Synergy Pharmaceuticals, Inc Common Stock position peaked at $716K in Q1 2014.
78 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.